Swedish Orphan Biovitrum AB - Company Profile

Powered by

All the data and insights you need on Swedish Orphan Biovitrum AB in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Swedish Orphan Biovitrum AB Strategy Report

  • Understand Swedish Orphan Biovitrum AB position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Swedish Orphan Biovitrum AB: Executives

Select Item

Related keylists

The following section provides information on Swedish Orphan Biovitrum AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Swedish Orphan Biovitrum AB's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Annette Clancy

Chairman Executive Board Since: 2024 Age: 70

Ms. Annette Clancy has been the Chairman of the company since 2024. She served as non-executive director of the company. She has experience in executive positions and board positions in the pharmaceutical industry.

Read Hide full bio of Annette Clancy

Guido Oelkers

Chief Executive Officer Senior Management Since: 2017 Age: 58

Mr. Guido Oelkers has been the Chief Executive Officer of Swedish Orphan Biovitrum AB since 2017. Prior to this, he served as the President and Chief Executive Officer of Gambro. Mr. Oelkers also served as the Chief Executive Officer of Invida and held a number of executive commercial operations roles in Nycomed, DKSH Group and Aventis. Currently, he is also a member of the Board of Directors at Meda.

Read Hide full bio of Guido Oelkers

Henrik Stenqvist

Chief Financial Officer Senior Management Since: 2018 Age: 56

Mr. Henrik Stenqvist has been the Chief Financial Officer of the company since 2018. Prior to this, he was the Chief Financial Officer of Recipharm. Mr. Stenqvist also served as the Chief Financial Officer of Meda Group.

Read Hide full bio of Henrik Stenqvist

Lydia Abad-Franch

Chief Medical Officer; Head - Research, Development and Medical Affairs; Senior Vice President Senior Management Since: 2023

Ms. Lydia Abad-Franch has been the Chief Medical Officer of the company since 2023. She also serves as Senior Vice President and Head of Research, Development and Medical Affairs of the company. Previously, she served as Interim Chief Medical Officer of the company.

Read Hide full bio of Lydia Abad-Franch

Daniel Rankin

Head - Global Portfolio and Product Strategy Senior Management Since: 2017 Age: 43
Gain a 360-degree view of Swedish Orphan Biovitrum AB and make more informed decisions for your business Gain a 360-degree view of Swedish Orphan Biovitrum AB and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward